Rockefeller Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$274M Buy
1,883,578
+35,218
+2% +$4.87M 0.4% 51
2026
Q2
$238M Buy
1,848,360
+95,462
+5% +$11.2M 0.36% 54
2026
Q1
$211M Buy
1,752,898
+30,752
+2% +$3.55M 0.37% 49
2025
Q4
$181M Buy
1,722,146
+429,419
+33% +$40.3M 0.33% 58
2025
Q3
$108M Buy
1,292,727
+46,549
+4% +$3.83M 0.21% 92
2025
Q2
$98.6M Buy
1,246,178
+35,011
+3% +$2.78M 0.22% 96
2025
Q1
$109M Buy
1,211,167
+44,848
+4% +$4.19M 0.27% 72
2024
Q4
$116M Sell
1,166,319
-55,283
-5% -$5.7M 0.3% 64
2024
Q3
$139M Sell
1,221,602
-43,500
-3% -$5.17M 0.37% 51
2024
Q2
$157M Sell
1,265,102
-35,750
-3% -$4.61M 0.45% 32
2024
Q1
$172M Sell
1,300,852
-90,492
-7% -$11.2M 0.5% 30
2023
Q4
$152M Buy
1,391,344
+200,274
+17% +$20.8M 0.51% 32
2023
Q3
$123M Buy
1,191,070
+68,837
+6% +$7.42M 0.47% 37
2023
Q2
$128M Buy
1,122,233
+31,590
+3% +$3.59M 0.5% 30
2023
Q1
$116M Sell
1,090,643
-23,211
-2% -$2.51M 0.5% 34
2022
Q4
$124M Buy
1,113,854
+25,318
+2% +$2.59M 0.62% 20
2022
Q3
$93.7M Buy
1,088,536
+200,947
+23% +$17.9M 0.48% 42
2022
Q2
$80.9M Buy
887,589
+64,672
+8% +$5.73M 0.43% 54
2022
Q1
$67.5M Buy
822,917
+102,128
+14% +$8.05M 0.33% 67
2021
Q4
$55.2M Buy
720,789
+15,272
+2% +$1.22M 0.26% 92
2021
Q3
$53M Buy
705,517
+17,426
+3% +$1.33M 0.28% 77
2021
Q2
$53.5M Sell
688,091
-36,563
-5% -$2.72M 0.3% 75
2021
Q1
$55.9M Buy
724,654
+59,421
+9% +$4.59M 0.38% 56
2020
Q4
$54.4M Buy
665,233
+39,352
+6% +$3.15M 0.41% 54
2020
Q3
$51.9M Buy
625,881
+36,409
+6% +$2.99M 0.49% 40
2020
Q2
$45.6M Buy
589,472
+103,356
+21% +$8.15M 0.48% 44
2020
Q1
$37.4M Buy
486,116
+111,175
+30% +$9.16M 0.49% 40
2019
Q4
$34.1M Buy
374,941
+21,016
+6% +$1.81M 0.43% 52
2019
Q3
$29.8M Buy
353,925
+62,718
+22% +$5.27M 0.4% 57
2019
Q2
$24.4M Sell
291,207
-56,401
-16% -$4.53M 0.34% 68
2019
Q1
$28.9M Buy
347,608
+69,233
+25% +$5.43M 0.41% 55
2018
Q4
$21.3M Sell
278,375
-22,501
-7% -$1.66M 0.37% 67
2018
Q3
$21.3M Buy
300,876
+863
+0.3% +$57.6K 0.32% 76
2018
Q2
$18.2M Sell
300,013
-111,182
-27% -$6.57M 0.3% 77
2018
Q1
$22.4M Sell
411,195
-31,404
-7% -$1.78M 0.37% 73
2017
Q4
$24.9M Buy
442,599
+215,339
+95% +$12.5M 0.39% 64
2017
Q3
$14.6M Buy
227,260
+809
+0.4% +$51.4K 0.28% 83
2017
Q2
$14.5M Sell
226,451
-278,059
-55% -$17.7M 0.29% 80
2017
Q1
$32.1M Buy
504,510
+1,429
+0.3% +$90.9K 0.64% 41
2016
Q4
$29.6M Sell
503,081
-37,365
-7% -$2.29M 0.6% 43
2016
Q3
$33.7M Sell
540,446
-1,548,999
-74% -$94.9M 0.7% 44
2016
Q2
$120M Buy
2,089,445
+11,678
+0.6% +$651K 2.41% 6
2016
Q1
$110M Sell
2,077,767
-46,105
-2% -$2.37M 2.13% 14
2015
Q4
$112M Sell
2,123,872
-5,471
-0.3% -$289K 2.18% 6
2015
Q3
$105M Buy
2,129,343
+150,614
+8% +$8.38M 2.14% 12
2015
Q2
$113M Buy
1,978,729
+138,607
+8% +$8.15M 2.33% 7
2015
Q1
$106M Buy
1,840,122
+93,506
+5% +$5.55M 2.29% 11
2014
Q4
$99.2M Sell
1,746,616
-11,902
-0.7% -$695K 2.17% 13
2014
Q3
$104M Buy
1,758,518
+26,224
+2% +$1.54M 2.32% 7
2014
Q2
$100M Sell
1,732,294
-27,888
-2% -$1.59M 2.25% 6
2014
Q1
$100M Buy
1,760,182
+6,060
+0.3% +$329K 2.16% 5
2013
Q4
$87.8M Buy
1,754,122
+246,298
+16% +$11.8M 1.9% 7
2013
Q3
$71.8M Sell
1,507,824
-194,366
-11% -$9.3M 1.67% 14
2013
Q2
$79.1M Hold
1,702,190
– – 1.9% 9

Other funds holding MRK

Rockefeller Capital Management's MRK Position: Q3 2026 in Review

Rockefeller Capital Management increased its Merck (MRK) stake by 1.9% in Q3 2026, buying an estimated $4.87M and bringing the position to 1,883,578 shares worth $274M. The position accounts for 0.4% of the portfolio, ranked #51.

Rockefeller Capital Management first reported a position in MRK in Q2 2013 and has held it in 54 quarters since. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Rockefeller Capital Management held 1,883,578 shares of Merck worth $274M as of Q3 2026.
  • Rockefeller Capital Management bought 35,218 Merck shares in Q3 2026, an estimated $4.87M.
  • Merck made up 0.4% of Rockefeller Capital Management's portfolio in Q3 2026, its #51 holding.
  • Rockefeller Capital Management first reported a position in Merck in Q2 2013 and has held it in 54 quarters since.
  • 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.